"From Lab to Life: Windlas Biotech's Dedication to Health and Wellness"
ABOUT OUR HERITAGE
Windlas family has been in business since 2001. Our journey has been
exciting and rewarding with a successful track record of different
products, customers and teams.
Windlas Biotech has become one of India’s leading Generic Formulations CDMO
manufacturers in a short span. We have done this with our commitment to all the
stakeholders, from clients to investors. This pushes us to deliver not only high-quality
products but also great profitability.
Cruising along the same path, we have also had a significant impact with our Trade
Generics & Institutional Business vertical, which is growing at a steady pace. With
tremendous potential, this vertical will set the ground for future growth.
Riding on the pillars of Scalability, Durability and Profitability, Windlas Biotech is all set
to make a deep dent in the industry following our successful IPO and complete fund
utilization from the same.
Plant 1 established and production started.
Set up of own brand (Marketing Division)
Ventured into the Markets. Crossed Rs 100 Cr revenue
by Windlas Healthcare plant
Plant 2 set up comissioned and crossed Rs. 200 Cr.
1st USFDA inspection cleared for Windlas Healthcare plant
Received private equity investment from Tano Capital
Crossed Rs. 300 Cr. turnover.
Plant 3 set up completed. Launched 1st product in US from WHC